INBS
Intelligent Bio Solutions Inc.NASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$6.15M
P/E Ratio
—
EPS
$-11.62
Beta
4.24
52W High
$24.90
52W Low
$2.27
50-Day MA
$2.97
200-Day MA
$8.07
Dividend Yield
—
Profit Margin
-296.80%
Forward P/E
—
PEG Ratio
—
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (INBS) is a forward-thinking biotechnology firm specializing in the development of advanced diagnostic solutions and biomarker-driven technologies for drug abuse testing and monitoring. The company's innovative approach harnesses state-of-the-art scientific methodologies to deliver rapid and accurate testing options, enabling timely clinical decision-making and enhancing patient outcomes. As the demand for sophisticated diagnostic tools continues to rise, INBS is strategically positioned to lead the transformation of healthcare diagnostics, underscoring its commitment to improving healthcare quality and efficiency.
Fundamentals
| Revenue (TTM) | $3.91M |
| Gross Profit (TTM) | $1.85M |
| EBITDA | $-10.23M |
| Operating Margin | -277.30% |
| Return on Equity | -170.20% |
| Return on Assets | -57.30% |
| Revenue/Share (TTM) | $3.83 |
| Book Value | $8.96 |
| Price-to-Book | 0.69 |
| Price-to-Sales (TTM) | 1.57 |
| EV/Revenue | 0.29 |
| EV/EBITDA | -0.91 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 45.50% |
| Shares Outstanding | $2.39M |
| Float | $2.17M |
| % Insiders | 3.57% |
| % Institutions | 8.71% |
Historical Volatility
HV 10-Day
225.85%
HV 20-Day
160.24%
HV 30-Day
139.68%
HV 60-Day
119.21%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026